Your browser doesn't support javascript.
loading
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
Schindler, Suzanne E; Li, Yan; Todd, Kaitlin W; Herries, Elizabeth M; Henson, Rachel L; Gray, Julia D; Wang, Guoqiao; Graham, Danielle L; Shaw, Leslie M; Trojanowski, John Q; Hassenstab, Jason J; Benzinger, Tammie L S; Cruchaga, Carlos; Jucker, Mathias; Levin, Johannes; Chhatwal, Jasmeer P; Noble, James M; Ringman, John M; Graff-Radford, Neill R; Holtzman, David M; Ladenson, Jack H; Morris, John C; Bateman, Randall J; Xiong, Chengjie; Fagan, Anne M.
Afiliação
  • Schindler SE; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Li Y; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
  • Todd KW; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
  • Herries EM; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Henson RL; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
  • Gray JD; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
  • Wang G; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
  • Graham DL; Biomarkers, Research and Early Development, Biogen, Cambridge, MA, USA.
  • Shaw LM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Trojanowski JQ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hassenstab JJ; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Benzinger TLS; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Cruchaga C; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
  • Jucker M; German Center for Neurodegenerative Diseases (DZNE), Germany; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Levin J; German Center for Neurodegenerative Diseases (DZNE), Germany; Department of Neurology, Ludwig Maximilians University, Munich, Germany.
  • Chhatwal JP; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Noble JM; Department of Neurology, Columbia University Medical Center, New York City, NY, USA.
  • Ringman JM; Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
  • Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Holtzman DM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
  • Ladenson JH; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Morris JC; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
  • Xiong C; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
  • Fagan AM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. Elect
Alzheimers Dement ; 15(5): 655-665, 2019 05.
Article em En | MEDLINE | ID: mdl-30846386
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Progressão da Doença / Doença de Alzheimer / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Progressão da Doença / Doença de Alzheimer / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos